1192 Bull. Chem. Soc. Jpn., 77, No. 6 (2004)
Hydrolysis of Dipeptides by CPD-Y and CPD-A
Calcd for C22H24N2O5: C, 66.65; H, 6.10; N, 7.06%.
no acid (Xaa = D, L-Ala, Gly, NMeAla, D, L-Pro, Aib, Sar, Phe, and
Tyr) with thionyl chloride, followed by MeOH, gave the corre-
sponding methyl ester (HCl Xaa–OMe). The coupling reactions
N-Benzyloxycarbonyl-L-phenylalanyl-sarcosine
20
(Z–Phe–
Sar). mp 61–63 ꢄC, (lit.20 46–50 ꢄC), ½ꢀꢂD ꢁ9:4, (c 0.40, EtOH),
ꢆ
20
were mediated by dicyclohexylcarbodiimide to give the corre-
sponding N- and O-protected dipeptides (Z–Phe–Xaa–OMe).
Methylation of Z–Phe–Tyr–OMe with methyl iodide gave Z–
Phe–Tyr(O–Me)–OMe. Deprotection of the C-terminus of the di-
peptides was carried out by treatment with an equivalent amount
of 1 M NaOHaq for 0.5–3 h at room temperature to give the dipep-
tide substrates, Z–Phe–Xaa.
(lit.20 ½ꢀꢂD ꢁ9:5, c 4.0, EtOH), 1H NMR (500 MHz, CDCl3) ꢁ
7.34–7.15 (10H, m), 5.91 (1H, d, J ¼ 9:0 Hz), 5.08 (1H, d, J ¼
12:5 Hz), 5.02 (1H, d, J ¼ 12:5 Hz), 4.95 (1H, q, J ¼ 8:2 Hz),
4.20 (1H, d, J ¼ 17:5 Hz), 3.94 (1H, d, J ¼ 17:5 Hz), 3.07–2.94
(2H, m), 2.88 (3H, s). Found: C, 64.71; H, 6.24; N, 7.45%. Calcd
for C20H22N2O5: C, 64.85; H, 5.99; N, 7.56%. FABMS m/z
371.1639. Calcd for C20H23N2O5 371.1608.
N-Benzyloxycarbonyl-L-phenylalanyl-2-methylalanine (Z–
20
N-Benzyloxycarbonyl-L-phenylalanyl-L-phenylalanine (Z–
20
Phe–Aib). mp 158 ꢄC, (lit.16 161 ꢄC), ½ꢀꢂD ꢁ9:7, (c 0.10,
Phe–Phe). mp 155–156 ꢄC, (lit.21 158–160 ꢄC), ½ꢀꢂD ꢁ6:89,
20
MeOH), (lit.16 ½ꢀꢂD ꢁ9:5, c 0.1, MeOH), 1H NMR (500 MHz,
(c 0.100, MeOH), 1H NMR (500 MHz, CDCl3) ꢁ 7.34–7.00
(15H, m), 6.51 (1H, d, J ¼ 6:4 Hz), 5.41 (1H, d, J ¼ 7:1 Hz),
5.05 (2H, s), 4.78–4.74 (1H, m), 4.46 (1H, m), 3.15–3.11 (1H,
m), 3.04–2.94 (3H, m). FABMS m/z 445.1766. Calcd for
C26H25N2O5 445.1765.
CDCl3) ꢁ 7.47–7.05 (10H, m), 6.48 (1H, s), 5.69 (1H, s), 5.08
(2H, s), 4.48 (1H, m), 3.05 (2H, m), 1.55 (3H, s), 1.42 (3H, s).
FABMS m/z 383.1613. Calcd for C21H23N2O5 383.1608.
N-Benzyloxycarbonyl-L-phenylalanyl-D-alanine (Z–Phe–D-
20
Ala). mp 155–156 ꢄC, ½ꢀꢂD ꢁ2:9, (c 0.10, MeOH), 1H NMR
N-Benzyloxycarbonyl-L-phenylalanyl-L-tyrosine [Z–Phe–
20
ꢄ
ꢄ
(500 MHz, CDCl3) ꢁ 7.45–7.16 (10H, m), 6.97 (1H, d, J ¼ 6:5
Hz), 6.01 (1H, d, J ¼ 8:5 Hz), 5.03 (1H, d, J ¼ 12:5 Hz), 4.95
(1H, d, J ¼ 12:5 Hz), 4.66 (1H, d, J ¼ 7:5 Hz), 4.45 (1H, q, J ¼
6:5 Hz), 3.00 (2H, d, J ¼ 6:0 Hz), 1.19 (3H, d, J ¼ 6:5 Hz).
FABMS m/z 371.1612. Calcd for C20H23N2O5 371.1608.
Phe(p-OH)]. mp 180–182 C, (lit.22 182–185 C), ½ꢀꢂD ꢁ2:56,
(c 0.100, MeOH), 1H NMR (500 MHz, CD3OD) ꢁ 7.31–7.15
(10H, m), 7.01 (2H, d, J ¼ 8:6 Hz), 6.68 (2H, d, J ¼ 8:2 Hz),
5.02 (1H, d, J ¼ 12:5 Hz), 4.96 (1H, d, J ¼ 12:8 Hz), 4.59–4.57
(1H, m), 4.38–4.35 (1H, m), 3.10–3.06 (2H, m), 2.93–2.89 (1H,
m), 2.79–2.74 (1H, m). FABMS m/z 461.1709. Calcd for
C26H25N2O6 461.1714.
N-Benzyloxycarbonyl-L-phenylalanyl-L-alanine (Z–Phe–L-
20
Ala). mp 160–162 ꢄC (lit.17 165 ꢄC), ½ꢀꢂD ꢁ10:8, (c 0.0198,
20
MeOH), (lit.17 ½ꢀꢂD ꢁ11:0, c 2, alcohol), 1H NMR (500 MHz,
N-Benzyloxycarbonyl-L-phenylalanyl-O-methyl-L-tyrosine
20
ꢄ
CDCl3) ꢁ 7.47–7.05 (10H, m), 6.47 (1H, s), 5.41 (1H, s), 5.08
(2H, s), 4.52 (1H, q, J ¼ 7:5 Hz), 4.50 (1H, t, J ¼ 7:5 Hz), 3.10
(1H, q, J ¼ 7:5 Hz), 3.06 (1H, q, J ¼ 7:5 Hz), 1.38 (3H, d, J ¼
7:5 Hz). FABMS m/z 369.1452. Calcd for C20H21N2O5 369.1450.
N-Benzyloxycarbonyl-L-phenylalanyl-glycine (Z–Phe–Gly).
[Z–Phe–Phe(p-OMe)]. mp 120–121 C, ½ꢀꢂD ꢁ4:04, (c 0.120,
1
MeOH), H NMR (500 MHz, CDCl3) ꢁ 7.38–7.17 (8H, m), 7.12
(2H, d, J ¼ 7:3 Hz), 6.97 (2H, d, J ¼ 8:2 Hz), 6.72 (2H, d, J ¼
8:5 Hz), 5.52 (2H, d, J ¼ 7:1 Hz), 5.06 (1H, d, J ¼ 12:5 Hz),
5.00 (1H, d, J ¼ 11:9 Hz), 4.65–4.61 (1H, m), 4.41–4.36 (1H,
m), 3.71 (3H, s), 3.11–3.01 (2H, m), 2.96–2.87 (2H, m). FABMS
m/z 475.1870. Calcd for C27H27N2O6 475.1892.
Enzyme CPD-A and CPD-Y. CPD-Y prepared by Oriental
Yeast Co. Ltd., and CPD-A prepared by ICN Biomedicals, Inc.,
were purchased from Wako Pure Chemical Industries, and were
used without purification.
20
mp 144–147 ꢄC, (lit.18 154 ꢄC), ½ꢀꢂD ꢁ9:9, (c 0.025, AcOH),
18
1
(lit.18 ½ꢀꢂD ꢁ10:2, c 2.73, AcOH), H NMR (500 MHz, CDCl3)
ꢁ 7.47–7.05 (10H, m), 6.52 (1H, s), 5.39 (1H, s), 5.07 (2H, s),
4.54 (1H, dd, J ¼ 6:5, 12.5 Hz), 4.06 (1H, d, J ¼ 17:9 Hz), 3.92
(1H, d, J ¼ 17:9 Hz), 3.96–3.92 (1H, m), 3.08 (2H, m). Found:
C, 63.94; H, 5.57; N, 7.92%. Calcd for C19H20N2O5: C, 64.04;
H, 5.66; N; 7.68%.
Kinetic Measurements. A spectrophotometer was used for ki-
netic measurements. Kinetics were measured by following the de-
crease in the absorbance at 230–240 nm. The reaction conditions
were kept constant over all of the kinetic measurements: tempera-
ture, 310 K; concentration of the buffer, 50 mM; and pH, 6.5.
As a typical procedure for these experiments, carboxypeptidase-
Y (4.68 mg, 7:8 ꢃ 10ꢁ8 mol) was dissolved into Tris–HCl buffer
(1 mL), and carboxypeptidase-A (1.46 mg, 4:2 ꢃ 10ꢁ8 mol) was
dissolved into Tris–HCl buffer (3 mL); the solutions were then
diluted appropriately. A stock solution of the substrate was pre-
pared as ca. 1 mM solutions by dissolving the substrate into
Tris–HCl buffer and diluting appropriately. The solution of the
substrate (3 mL) was placed in a thermostated compartment of
the spectrophotometer and incubated for 5 min. In inhibition stud-
ies, a mixture of a Z–Phe–L-Pro solution as substrate (2 mL) and a
Z–Phe–D-Xaa (Xaa = Pro or Ala) solution as inhibitor (1 mL) was
placed in a thermostated compartment of the spectrophotometer
and incubated for 5 min. After 20 mL of the enzyme solution
was added, the mixture was shaken to make it homogeneous.
The absolute absorbance of this solution was then measured. One
set of measurements was composed of data from 5 different
substrate concentrations, and the initial velocity of each substrate
concentration was calculated as the average of 3–5 runs. The di-
peptides and the hydrolysis products of dipeptide Z–Phe–Xaa by
carboxypeptidase-Y and carboxypeptidase-A were checked by
N-Benzyloxycarbonyl-L-phenylalanyl-N-methyl-L-alanine
20
(Z–Phe–NMeAla). mp 39–40 ꢄC, ½ꢀꢂD ꢁ33:2, (c 0.100, MeOH);
1H NMR (500 MHz, CDCl3) ꢁ 7.33–7.16 (10H, m), 6.23 (1H, d,
J ¼ 9:0 Hz), 5.17 (1H, q, J ¼ 7:5 Hz), 5.12 (1H, d, J ¼ 8:5 Hz),
5.09 (1H, d, J ¼ 8:5 Hz), 4.95 (1H, quintet, J ¼ 7:4 Hz), 3.09–
2.94 (2H, m), 2.86 (3H, s), 1.39 (3H, d, J ¼ 7:5 Hz). Found: C,
65.47; H, 6.46; N, 7.19%. Calcd for C21H24N2O5: C, 65.63; H,
6.25; N, 7.29%.
N-Benzyloxycarbonyl-L-phenylalanyl-D-proline (Z–Phe–D-
20
ꢄ
Pro). mp 125–126 C, ½ꢀꢂD ꢁ38:5, (c 0.102, MeOH); 1H NMR
(500 MHz, CDCl3) ꢁ 7.33–7.19 (10H, m), 5.95 (1H, d, J ¼ 8:5
Hz), 5.10 (1H, d, J ¼ 12:5 Hz), 5.02 (1H, d, J ¼ 12:5 Hz), 4.75–
4.72 (1H, m), 4.35–4.32 (1H, m), 3.54 (1H, s), 3.15–3.06 (1H,
m), 2.99–2.98 (1H, m), 2.65–2.60 (1H, m), 2.06–2.01 (1H, m),
1.86–1.73 (2H, m), 1.54–1.49 (1H, m). FABMS m/z 397.1783.
Calcd for C22H25N2O5 397.1763.
N-Benzyloxycarbonyl-L-phenylalanyl-L-proline (Z–Phe–L-
20
ꢄ
ꢄ
Pro). mp 107–108 C, (lit.19 106.5 C), ½ꢀꢂD ꢁ43:7, (c 0.130,
MeOH), 1H NMR (500 MHz, CDCl3) ꢁ 7.37–7.12 (10H, m),
5.57 (1H, d, J ¼ 9:0 Hz), 5.11 (1H, d, J ¼ 12:5 Hz), 5.06 (1H,
d, J ¼ 12:5 Hz), 4.69 (1H, dd, J ¼ 8:0, 15.1 Hz), 4.58 (1H, d, J ¼
5:5 Hz), 3.51 (1H, dd, J ¼ 8:5, 15.9 Hz), 3.06–3.03 (2H, m), 2.85–
2.80 (1H, m), 2.34–2.30 (1H, m), 2.01–1.93 (1H, m), 1.89–1.83
(1H, m), 1.78–1.71 (1H, m). Found: C, 66.64; H, 6.13; N 6.90%.